Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer

References

• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191–e203. doi:10.1016/S2214-109X(19)30482-6
   PubMed Web of Science ®Google Scholar
• Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45:2640–2648. doi:10.1016/j.ejca.2009.07.018
   PubMed Web of Science ®Google Scholar
• Andrae B, Andersson TML, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ. 2012;344:e900–e900. doi:10.1136/bmj.e900
   Web of Science ®Google Scholar
• Bos AB, Rebolj M, Habbema JDF, Van Ballegooijen M. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer. 2006;119:2372–2375. doi:10.1002/ijc.22114
   PubMed Web of Science ®Google Scholar
• Andrae B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100:622–629. doi:10.1093/jnci/djn099
   PubMedGoogle Scholar
• Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med (Baltim). 2007;45:93–106. doi:10.1016/j.ypmed.2007.06.007
   PubMed Web of Science ®Google Scholar
• Stenkvist B, Söderström J. Reasons for cervical cancer despite extensive screening. J Med Screen. 1996;3:204–207. doi:10.1177/096914139600300409
   Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;k4823. doi:10.1136/bmj.k4823
   Web of Science ®Google Scholar
• Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJF, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51:2375–2385. doi:10.1016/j.ejca.2015.07.006
   PubMed Web of Science ®Google Scholar
• Hawkes D, Keung MHT, Huang Y, et al. Self-collection for cervical screening programs: from research to reality. Cancers (Basel). 2020;12:1053. doi:10.3390/cancers12041053
   Web of Science ®Google Scholar
• Meijer CJLM, Berkhof J, Castle PE, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009;124:516–520. doi:10.1002/ijc.24010
   PubMed Web of Science ®Google Scholar
• Arbyn M, Verdoodt F, Snijders PJF, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15:172–183. doi:10.1016/S1470-2045(13)70570-9
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer. 2013;49:3262–3273. doi:10.1016/j.ejca.2013.04.024
   PubMed Web of Science ®Google Scholar
• IARC. IARC Handbooks of Cancer Prevention Cervix Cancer Screening. IARC; 2005.
   Google Scholar
• Arbyn M, Bruni L, Kelly D, et al. Tackling cervical cancer in Europe amidst the COVID-19 pandemic. Lancet Public Health. 2020;5:e425. doi:10.1016/S2468-2667(20)30122-5
   PubMed Web of Science ®Google Scholar
• Poljak M, Cuschieri K, Waheed DEN, Baay M, Vorsters A. Impact of the covid-19 pandemic on human papillomavirus–based testing services to support cervical cancer screening. Acta Dermatovenerologica Alpina Pannonica Adriat. 2021;30:21–26. doi:10.15570/actaapa.2021.5.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Gultekin M, Morice P, et al. The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 2021;148:277–284. doi:10.1002/ijc.33189
   PubMed Web of Science ®Google Scholar
• WHO NCD Department. Final Results Rapid Assessment of Service Delivery for Noncommunicable Disease During the COVID-19 Pandemic. WHO; 2020.
   Google Scholar
• Epic Health Research Network. Delayed cancer screenings—a second look; 2021. https://ehrn.org/articles/delayed-cancer-screenings-a-second-look//index.html. Accessed May 1, 2021.
   Google Scholar
• Ivanuš U, Jerman T, Gašper Oblak U, et al. The impact of the COVID-19 pandemic on organised cervical cancer screening: the first results of the Slovenian cervical screening programme and registry. Lancet Reg Health Eur. 2021;5:100101. doi:10.1016/j.lanepe.2021.100101
   PubMedGoogle Scholar
• Australian Institute of Health and Welfare. Cancer screening and COVID-19 in Australia. 2021.
   Google Scholar
• Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21:750–751. doi:10.1016/S1470-2045(20)30265-5
   PubMed Web of Science ®Google Scholar
• Tsibulak I, Reiser E, Bogner G, et al. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective. Int J Gynecol Cancer. 2020;30:1667–1671. doi:10.1136/ijgc-2020-001975
   Web of Science ®Google Scholar
• Skovlund CW, Friis S, Dehlendorff C, Nilbert MC, Mørch LS. Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta Oncol (Madr). 2021;60:20–23. doi:10.1080/0284186X.2020.1858235
   PubMed Web of Science ®Google Scholar
• Jacob L, Loosen SH, Kalder M, Luedde T, Roderburg C, Kostev K. Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers (Basel). 2021;13:408. doi:10.3390/cancers13030408
   PubMed Web of Science ®Google Scholar
• Maluchnik M, Podwójcic K, Więckowska B. Decreasing access to cancer diagnosis and treatment during the COVID-19 pandemic in Poland. Acta Oncol (Madr). 2021;60:28–31. doi:10.1080/0284186X.2020.1837392
   PubMed Web of Science ®Google Scholar
• Castanon A, Rebolj M, Pesola F, Sasieni P. Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses. Br J Cancer. 2021;124:1361–1365. doi:10.1038/s41416-021-01275-3
   PubMed Web of Science ®Google Scholar
• Miller MJ, Xu L, Qin J, et al. Impact of COVID-19 on cervical cancer screening rates among women aged 21–65 years in a large integrated health care system — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:109–113. doi:10.15585/mmwr.mm7004a1
   Web of Science ®Google Scholar
• Uppal S, Chapman C, Spencer RJ, et al. Association of hospital volume with racial and ethnic disparities in locally advanced cervical cancer treatment. Obstet Gynecol. 2017;129:295–304. doi:10.1097/AOG.0000000000001819
   Web of Science ®Google Scholar
• White A, Thompson TD, White MC, et al. Cancer screening test use — United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201–206. doi:10.15585/mmwr.mm6608a1
   PubMed Web of Science ®Google Scholar
• Beavis AL, Gravitt PE, Rositch AF. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer. 2017;123:1044–1050. doi:10.1002/cncr.30507
   PubMed Web of Science ®Google Scholar
• Tracy JK, Lydecker AD, Ireland L. Barriers to cervical cancer screening among lesbians. J Womens Health (Larchmt). 2010;19:229–237. doi:10.1089/jwh.2009.1393
   PubMed Web of Science ®Google Scholar
• Paskett ED, McLaughlin JM, Reiter PL, et al. Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project. Prev Med (Baltim). 2010;50:74–80. doi:10.1016/j.ypmed.2009.09.001
   PubMed Web of Science ®Google Scholar
• Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer. 2020;6:e21697. doi:10.2196/21697
   Web of Science ®Google Scholar
• MacLaughlin KL, Jacobson RM, Radecki Breitkopf C, et al. Trends over time in pap and pap-HPV cotesting for cervical cancer screening. J Womens Health. 2019;28:244–249. doi:10.1089/jwh.2018.7380
   PubMed Web of Science ®Google Scholar
• Thompson D, Lei Y. Mini review: recent progress in RT-LAMP enabled COVID-19 detection. Sensor Actuator Rep. 2020;2:100017. doi:10.1016/j.snr.2020.100017
   PubMedGoogle Scholar
• Gao J, Wu L, Yang D, Gong W, Wang J, One-Pot A. CRISPR/Cas9-typing PCR for DNA detection and genotyping. J Mol Diagn. 2021;23:46–60. doi:10.1016/j.jmoldx.2020.10.004
   Web of Science ®Google Scholar
• Ramachandran A, Huyke DA, Sharma E, et al. Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117:29518–29525. doi:10.1073/pnas.2010254117
   PubMed Web of Science ®Google Scholar
• Sigurdsson K, Hrafnkelsson J, Geirsson G, Gudmundsson J, Salvarsdóttir A. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964–1988. Gynecol Oncol. 1991;43:64–70. doi:10.1016/0090-8258(91)90011-S
   PubMed Web of Science ®Google Scholar
• Landy R, Pesola F, Castañón A, Sasieni P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 2016;115:1140–1146. doi:10.1038/bjc.2016.290
   PubMed Web of Science ®Google Scholar
• Takač I, Uršič-Vrščaj M, Repše-Fokter A, et al. Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia. Eur J Obstet Gynecol Reprod Biol. 2008;140:82–89. doi:10.1016/j.ejogrb.2008.02.019
   Web of Science ®Google Scholar
• Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol Biomarkers Prev. 2015;24:769–772. doi:10.1158/1055-9965.EPI-14-1417
   PubMed Web of Science ®Google Scholar
• Yeh PT, Kennedy CE, De Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health. 2019;4:e001351. doi:10.1136/bmjgh-2018-001351
   Web of Science ®Google Scholar
• Sarai racey C, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health. 2013;104(2):e159–e166. doi:10.1007/bf03405681
   Web of Science ®Google Scholar
• Ivanus U, Jerman T, Fokter AR, et al. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiol Oncol. 2018;52:399–412. doi:10.2478/raon-2018-0036
   Web of Science ®Google Scholar
• Broberg G, Gyrd-Hansen D, Miao Jonasson J, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer. 2014;134:2223–2230. doi:10.1002/ijc.28545
   PubMed Web of Science ®Google Scholar
• Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial. BMC Cancer. 2018;18:1. doi:10.1186/s12885-018-4165-4.
   Web of Science ®Google Scholar
• Chao YS. HPV self-sampling for primary cervical cancer screening: a review of diagnostic test accuracy and clinical evidence – an update. Can Agency Drugs Technol Health. 2019.
   Google Scholar
• Forte T, Lockwood GA, McLachlin CM, Fekete S, Bryant HE. A first look at participation rates in cervical cancer screening programs in Canada. Curr Oncol. 2012;19:269–271. doi:10.3747/co.19.1188
   Web of Science ®Google Scholar
• Bishop E, Katz ML, Reiter PL. Acceptability of human papillomavirus self-sampling among a national sample of women in the United States. Biores Open Access. 2019;8:65–73. doi:10.1089/biores.2018.0040
   PubMed Web of Science ®Google Scholar
• Madzima TR, Vahabi M, Lofters A. Emerging role of HPV self-sampling in cervical cancer screening for hard-To-reach women. Can Fam Physician. 2017;63(8):597–601.
   PubMed Web of Science ®Google Scholar
• Scarinci IC, Litton AG, Garcés-Palacio IC, Partridge EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi delta. Womens Health Issues. 2013;23:e123–e130. doi:10.1016/j.whi.2012.12.003
   PubMed Web of Science ®Google Scholar
• Vanderpool RC, Jones MG, Stradtman LR, Smith JS, Crosby RA. Self-collecting a cervico-vaginal specimen for cervical cancer screening: an exploratory study of acceptability among medically underserved women in rural Appalachia. Gynecol Oncol. 2014;132:S21–S25. doi:10.1016/j.ygyno.2013.10.008
   Web of Science ®Google Scholar
• Reiter P, Richardson M. Acceptability of human papillomavirus self-test devices among women from high-risk populations. J Womens Health Issues Care. 2016;5(1). doi:10.4172/2325-9795.1000216
   Google Scholar
• Richman AR, Brewer NT, Liebman AK, Rinas AC, Smith JS. Optimising human papillomavirus self-testing for high risk women. Sex Transm Infect. 2011;87:118–122. doi:10.1136/sti.2010.046326
   Web of Science ®Google Scholar
• Katz ML, Zimmermann BJ, Moore D, Paskett ED, Reiter PL. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home. Women Health. 2017;57:1161–1177. doi:10.1080/03630242.2016.1243608
   PubMed Web of Science ®Google Scholar
• Reiter PL, McRee AL. Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21–26 years in the USA. J Fam Plan Reprod Heal Care. 2015;41:259–264. doi:10.1136/jfprhc-2014-101004
   Google Scholar
• Winer RL, Lin J, Tiro JA, et al. Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial. JAMA Netw Open. 2019;2:e1914729. doi:10.1001/jamanetworkopen.2019.14729
   PubMed Web of Science ®Google Scholar
• Racey CS, Gesink DC, Burchell AN, Trivers S, Wong T, Rebbapragada A. Randomized intervention of self-collected sampling for human papillomavirus testing in under-screened rural women: uptake of screening and acceptability. J Womens Health. 2016;25:489–497. doi:10.1089/jwh.2015.5348
   Web of Science ®Google Scholar
• Castle PE, Rausa A, Walls T, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med (Baltim). 2011;52:452–455. doi:10.1016/j.ypmed.2011.03.018
   PubMed Web of Science ®Google Scholar
• Organización Mundial de la Salud - OMS. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. WHO; 2013.
   Google Scholar
• Ginsburg O, Badwe R, Boyle P, et al. Changing global policy to deliver safe, equitable, and affordable care for women’s cancers. Lancet. 2017;389:871–880. doi:10.1016/S0140-6736(16)31393-9
   Web of Science ®Google Scholar
• Kamath Mulki A, Withers M. Human papilloma virus self-sampling performance in low- and middle-income countries. BMC Womens Health. 2021;21:1. doi:10.1186/s12905-020-01158-4.
   Web of Science ®Google Scholar
• Sancho-Garnier H, Tamalet C, Halfon P, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer. 2013;133(11):2681–2687. doi:10.1002/ijc.28283
   Web of Science ®Google Scholar
• Cadman L, Wilkes S, Mansour D, et al. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. J Med Screen. 2015;22:28–37. doi:10.1177/0969141314558785
   Web of Science ®Google Scholar
• Montealegre JR, Mullen PD, Jibaja-Weiss M, Vargas Mendez MM, Scheurer ME. Feasibility of cervical cancer screening utilizing self-sample human papillomavirus testing among Mexican immigrant women in Harris County, Texas: a pilot study. J Immigr Minor Health. 2015;17:704–712. doi:10.1007/s10903-014-0125-5
   Web of Science ®Google Scholar
• Abuelo CE, Levinson KL, Salmeron J, Sologuren CV, Fernandez MJV, Belinson JL. The peru cervical cancer screening study (PERCAPS): the design and implementation of a mother/daughter screen, treat, and vaccinate program in the peruvian jungle. J Community Health. 2014;39:409–415. doi:10.1007/s10900-013-9786-6
   Web of Science ®Google Scholar
• Fitzpatrick MB, El-Khatib Z, Katzenstein D, Pinsky BA, Chirenje ZM, McCarty K. Community-based self-collected human papillomavirus screening in rural Zimbabwe. BMC Public Health. 2019;19:1–8. doi:10.1186/s12889-019-6810-5.
   Web of Science ®Google Scholar
• Trope LA, Chumworathayi B, Blumenthal PD. Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand. J Low Genit Tract Dis. 2013;17:315–319. doi:10.1097/LGT.0b013e31826b7b70
   Web of Science ®Google Scholar
• Nakalembe M, Makanga P, Kambugu A, Laker-Oketta M, Huchko MJ, Martin J. A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision. Cancer Med. 2020;9:8701–8712. doi:10.1002/cam4.3468
   Web of Science ®Google Scholar
• Gök M, Van Kemenade FJ, Heideman DAM, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer. 2012;130:1128–1135. doi:10.1002/ijc.26128
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5:e132. doi:10.1371/journal.pmed.0050132
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R. Overview of cervical cancer in the developing world. Int J Gynecol Obstet. 2006;95:S205–S210. doi:10.1016/S0020-7292(06)60035-0
   Web of Science ®Google Scholar
• Ndejjo R, Mukama T, Musabyimana A, Musoke D. Uptake of cervical cancer screening and associated factors among women in rural Uganda: a cross sectional study. PLoS One. 2016;11:e0149696. doi:10.1371/journal.pone.0149696
   Web of Science ®Google Scholar
• Kuguyo O, Matimba A, Tsikai N, et al. Cervical cancer in Zimbabwe: a situation analysis. Pan Afr Med J. 2017;27:215. doi:10.11604/pamj.2017.27.215.12994
   Web of Science ®Google Scholar
• Research WA for HP and S. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. Outlook. 2003;II(1):33.
   Google Scholar
• Bin LJ, Simms KT, Smith MA, et al. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. Lancet Public Health. 2017;2(2):e96–e107. doi:10.1016/S2468-2667(17)30007-5
   Web of Science ®Google Scholar
• Tapera O, Kadzatsa W, Nyakabau AM, et al. Sociodemographic inequities in cervical cancer screening, treatment and care amongst women aged at least 25 years: evidence from surveys in Harare, Zimbabwe. BMC Public Health. 2019;19:1–2. doi:10.1186/s12889-019-6749-6
   Web of Science ®Google Scholar
• Nabirye J, Okwi LA, Nuwematsiko R, et al. Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9–15 years in Mbale District, Uganda. BMC Public Health. 2020;20:1. doi:10.1186/s12889-020-8302-z
   Web of Science ®Google Scholar
• Allen-Leigh B, Uribe-Zúñiga P, León-Maldonado L, et al. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study. BMC Cancer. 2017;17:1. doi:10.1186/s12885-017-3723-5
   Web of Science ®Google Scholar
• Brandt T, Wubneh SB, Handebo S, et al. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia. BMC Public Health. 2019;19:1–9. doi:10.1186/s12889-019-7354-4
   Web of Science ®Google Scholar
• Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. BMJ Open. 2017;7:e015048. doi:10.1136/bmjopen-2016-015048
   Web of Science ®Google Scholar
• Termrungruanglert W, Khemapech N, Tantitamit T, Sangrajrang S, Havanond P, Laowahutanont P. Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand. Gynecol Oncol Rep. 2017;22:58–63. doi:10.1016/j.gore.2017.09.007
   Web of Science ®Google Scholar
• Awua AK, Wiredu EK, Afari EA, Tijani AS, Djanmah G, Adanu RMK. A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana. BMC Public Health. 2017;18:1. doi:10.1186/s12889-017-4631-y
   Web of Science ®Google Scholar
• Huchko MJ, Ibrahim S, Blat C, et al. Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. Int J Gynecol Obstet. 2018;141:63–69. doi:10.1002/ijgo.12415
   PubMed Web of Science ®Google Scholar
• Fitzpatrick MB, Dube Mandishora RS, Katzenstein DA, et al. hrHPV prevalence and type distribution in rural Zimbabwe: a community-based self-collection study using near-point-of-care GeneXpert HPV testing. Int J Infect Dis. 2019;82:21–29. doi:10.1016/j.ijid.2019.02.022
   Web of Science ®Google Scholar
• Fitzpatrick M, Pathipati MP, McCarty K, et al. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe. BMC Womens Health. 2020;20:1. doi:10.1186/s12905-020-01017-2
   Web of Science ®Google Scholar
• Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:1–9. doi:10.1186/1471-2458-14-596.
   Web of Science ®Google Scholar
• Arriba LN, Enerson CL, Belinson S, Novick L, Belinson J. Mexican cervical cancer screening study ii: acceptability of human papillomavirus self-sampler. Int J Gynecol Cancer. 2010;20(8):1415-23. doi:10.1111/IGC.0b013e3181f58678
   Web of Science ®Google Scholar
• Arbyn M, Depuydt C, Benoy I, et al. VALGENT: a protocol for clinical validation of human papillomavirus assays. J Clin Virol. 2016;76:S14–S21. doi:10.1016/j.jcv.2015.09.014
   PubMed Web of Science ®Google Scholar
• Dutch National Institute for Public Health and the Environment. Annual Report RIVM. 2020.
   Google Scholar
• Smith M, Bin LJ, Simms K, Canfell K. Impact of HPV sample self-collection for underscreened women in the renewed cervical screening program. Med J Aust. 2016;204:194. doi:10.5694/mja15.00912
   Web of Science ®Google Scholar
• von Karsa L, Arbyn M, De VH, et al. European guidelines for quality assurance in cervical cancer screening - second edition supplements. Papillomavir Res. 2015;1:22–31. doi:10.1016/j.pvr.2015.06.006
   Web of Science ®Google Scholar
• Karjalainen L, Anttila A, Nieminen P, Luostarinen T, Virtanen A. Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device. BMC Cancer. 2016;16:1. doi:10.1186/s12885-016-2246-9.
   Web of Science ®Google Scholar
• Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer. 2011;128:2681–2687. doi:10.1002/ijc.25581
   PubMed Web of Science ®Google Scholar
• Polman NJ, Ebisch RMF, Heideman DAM, et al. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncol. 2019;20:229–238. doi:10.1016/S1470-2045(18)30763-0
   PubMed Web of Science ®Google Scholar
• Smith MA, Hall MT, Saville M, et al. Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiol Biomarkers Prev. 2021;30:268–277. doi:10.1158/1055-9965.EPI-20-0998
   Web of Science ®Google Scholar
• Bais AG, Van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120:1505–1510. doi:10.1002/ijc.22484
   PubMed Web of Science ®Google Scholar
• Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378:1868–1873. doi:10.1016/S0140-6736(11)61522-5
   PubMed Web of Science ®Google Scholar
• Bosgraaf RP, Verhoef VMJ, Massuger LFAG, et al. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer. 2015;136(3):646–655. doi:10.1002/ijc.29026
   PubMed Web of Science ®Google Scholar
• Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening- a randomised controlled trial. Br J Cancer. 2011;104:915–920. doi:10.1038/bjc.2011.48
   PubMed Web of Science ®Google Scholar
• Wikström I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105:337–339. doi:10.1038/bjc.2011.236
   PubMed Web of Science ®Google Scholar
• Surriabre P, Allende G, Prado M, et al. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA. BMC Womens Health. 2017;17:1–7. doi:10.1186/s12905-017-0490-z
   Web of Science ®Google Scholar
• Gök M, Heideman DAM, Van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:c1040–c1040. doi:10.1136/bmj.c1040
   PubMed Web of Science ®Google Scholar
• Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104:248–254. doi:10.1038/sj.bjc.6606040
   PubMed Web of Science ®Google Scholar
• Virtanen A, Nieminen P, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2011;20:1960–1969. doi:10.1158/1055-9965.EPI-11-0307
   PubMed Web of Science ®Google Scholar
• Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect. 2005;81:207–212. doi:10.1136/sti.2004.011858
   PubMed Web of Science ®Google Scholar
• Hillemanns P, Kimmig R, Hüttemann U, Dannecker C, Thaler CJ. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet. 1999;354:1970. doi:10.1016/S0140-6736(99)04110-0
   PubMed Web of Science ®Google Scholar
• Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol. 2004;15:863–869. doi:10.1093/annonc/mdh240
   PubMed Web of Science ®Google Scholar
• Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ. 2000;163(5):513–518.
   PubMed Web of Science ®Google Scholar
• Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen. 2009;16:193–198. doi:10.1258/jms.2009.009069
   PubMed Web of Science ®Google Scholar
• Leinonen MK, Schee K, Jonassen CM, et al. Safety and acceptability of human papillomavirus testing of self-collected specimens: a methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions. J Clin Virol. 2018;99–100:22–30. doi:10.1016/j.jcv.2017.12.008
   Web of Science ®Google Scholar
• Enerly E, Bonde J, Schee K, Pedersen H, Lönnberg S, Nygård M. Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme. PLoS One. 2016;11:e0151978. doi:10.1371/journal.pone.0151978
   PubMed Web of Science ®Google Scholar
• Lefeuvre C, Pivert A, Guillou-Guillemette H, et al. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France. J Infect. 2020;81:248–254. doi:10.1016/j.jinf.2020.05.006
   Web of Science ®Google Scholar
• Van Keer S, Tjalma WAA, Pattyn J, et al. Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples. Eur J Clin Microbiol Infect Dis. 2018;37:859–869. doi:10.1007/s10096-017-3179-1
   PubMed Web of Science ®Google Scholar
• Sargent A, Fletcher S, Bray K, Kitchener HC, Crosbie EJ. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening. BMJ Open. 2019;9:e025388. doi:10.1136/bmjopen-2018-025388
   PubMed Web of Science ®Google Scholar
• Cadman L, Reuter C, Jitlal M, et al. A randomized comparison of different vaginal self-sampling devices and urine for human papillomavirus testing-predictors 5.1. Cancer Epidemiol Biomarkers Prev. 2021;30:661–668. doi:10.1158/1055-9965.EPI-20-1226
   Web of Science ®Google Scholar
• Tranberg M, Jensen JS, Bech BH, Andersen B. Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays. BMC Infect Dis. 2020;20:1. doi:10.1186/s12879-020-05663-7.
   Web of Science ®Google Scholar
• Pathak N, Dodds J, Zamora J, Khan K. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ. 2014;349:g5264–g5264. doi:10.1136/bmj.g5264
   PubMed Web of Science ®Google Scholar
• Ørnskov D, Jochumsen K, Steiner PH, Grunnet IM, Lykkebo AW, Waldstrøm M. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for hpv testing among women referred for colposcopy. a cross-sectional study. BMJ Open. 2021;11:e041512. doi:10.1136/bmjopen-2020-041512
   Web of Science ®Google Scholar
• Stanczuk GA, Currie H, Baxter G, et al. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment. J Clin Pathol. 2015;68:567–570. doi:10.1136/jclinpath-2014-202851
   Web of Science ®Google Scholar
• Cho HW, Ouh YT, Hong JH, et al. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay. J Virol Methods. 2019;269:77–82. doi:10.1016/j.jviromet.2019.04.012
   PubMed Web of Science ®Google Scholar
• Cuzick J, Cadman L, Ahmad AS, et al. Performance and diagnostic accuracy of a urine-based human papillomavirus assay in a referral population. Cancer Epidemiol Biomarkers Prev. 2017;26:1053–1059. doi:10.1158/1055-9965.EPI-16-0960
   Web of Science ®Google Scholar
• Colli-Pee: An innovative solution for non-invasive urine collection and stabilization [homepage on the Internet]. Novosanis. Available from: https://novosanis.com/our-products. Accessed May 16, 2021.
   Google Scholar
• Huynh J, Howard M, Lytwyn A. Self-collection for vaginal human papillomavirus testing: systematic review of studies asking women their perceptions. J Low Genit Tract Dis. 2010;14:356–362. doi:10.1097/LGT.0b013e3181dc115b
   PubMed Web of Science ®Google Scholar
• Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health. 2011;20:397–402. doi:10.1089/jwh.2010.2189
   Web of Science ®Google Scholar
• Wikström I, Stenvall H, Wilander E. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Acta Obstet Gynecol Scand. 2007;86:720–725. doi:10.1080/00016340701303747
   PubMed Web of Science ®Google Scholar
• Polman NJ, de Haan Y, Veldhuijzen NJ, et al. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Prev Med (Baltim). 2019;125:5–11. doi:10.1016/j.ypmed.2019.04.025
   PubMed Web of Science ®Google Scholar
• Shin HY, Lee B, Hwang SH, et al. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected pap test vs. HPV test by self-sampling vs. HPV test by urine sampling. J Gynecol Oncol. 2019;30(5):e76. doi:10.3802/jgo.2019.30.e76
   Web of Science ®Google Scholar
• Sultana F, Mullins R, Murphy M, et al. Women’s views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting. Sex Health. 2015;12:279. doi:10.1071/SH14236
   Web of Science ®Google Scholar
• Ketelaars PJW, Bosgraaf RP, Siebers AG, et al. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: results of the VERA study. Prev Med (Baltim). 2017;101:96–101. doi:10.1016/j.ypmed.2017.05.021
   PubMed Web of Science ®Google Scholar
• Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A. Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol. 2014;135:487–494. doi:10.1016/j.ygyno.2014.09.019
   Web of Science ®Google Scholar
• Arrossi S, Ramos S, Straw C, Thouyaret L, Orellana L. HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country. BMC Public Health. 2016;16:1. doi:10.1186/s12889-016-3474-2.
   Web of Science ®Google Scholar
• Waller J, McCaffery K, Forrest S, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen. 2006;13:208–213. doi:10.1177/096914130601300409
   PubMed Web of Science ®Google Scholar
• Castle PE, Silva VRS, Consolaro MEL, et al. Participation in cervical screening by selfcollection, pap, or a choice of either in Brazil. Cancer Prev Res. 2019;12:159–170. doi:10.1158/1940-6207.CAPR-18-0419
   PubMed Web of Science ®Google Scholar
• Kellen E, Benoy I, Vanden Broeck D, et al. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program. Int J Cancer. 2018;143:861–868. doi:10.1002/ijc.31391
   Web of Science ®Google Scholar
• Montealegre JR, Landgren RM, Anderson ML, et al. Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol. 2015;138:317–322. doi:10.1016/j.ygyno.2015.05.028
   PubMed Web of Science ®Google Scholar
• Sultana F, Mullins R, English DR, et al. Women’s experience with home-based self-sampling for human papillomavirus testing. BMC Cancer. 2015;15:1. doi:10.1186/s12885-015-1804-x
   Web of Science ®Google Scholar
• Bosgraaf RP, Ketelaars PJW, Verhoef VMJ, et al. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med (Baltim). 2014;64:108–113. doi:10.1016/j.ypmed.2014.04.011
   PubMed Web of Science ®Google Scholar
• Forrest S, McCaffery K, Waller J, et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen. 2004;11:85–88. doi:10.1258/096914104774061065
   PubMed Web of Science ®Google Scholar
• Kahn JA, Bernstein DI, Rosenthal SL, et al. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect. 2005;81:408–414. doi:10.1136/sti.2004.012047
   PubMed Web of Science ®Google Scholar
• Crofts V, Flahault E, Tebeu PM, et al. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health. 2015;7:149. doi:10.2147/IJWH.S56307.
   Google Scholar
• Chen SL, Hsieh PC, Chou CH, Tzeng YL. Determinants of women’s likelihood of vaginal self-sampling for human papillomavirus to screen for cervical cancer in Taiwan: a cross-sectional study. BMC Womens Health. 2014;14:1–7. doi:10.1186/s12905-014-0139-0
   Web of Science ®Google Scholar
• Galbraith KV, Gilkey MB, Smith JS, Richman AR, Barclay L, Brewer NT. Perceptions of mailed HPV self-testing among women at higher risk for cervical cancer. J Community Health. 2014;39:849–856. doi:10.1007/s10900-014-9931-x
   Web of Science ®Google Scholar
• Ndukwe EG, Williams KP, Sheppard V. Knowledge and perspectives of breast and cervical cancer screening among female African immigrants in the Washington D.C. metropolitan area. J Cancer Educ. 2013;28:748–754. doi:10.1007/s13187-013-0521-x
   PubMed Web of Science ®Google Scholar
• Frota da Rocha Morgado F, Kopp Xavier da Silveira EM, Pinheiro Rodrigues Do Nascimento L, et al. Psychometric assessment of the EMIC Stigma Scale for Brazilians affected by leprosy. PLoS One. 2020;15:e0239186. doi:10.1371/journal.pone.0239186
   Web of Science ®Google Scholar
• Were E, Nyaberi Z, Buziba N. Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya. Afr Health Sci. 2011;11(1):58-64.
   Web of Science ®Google Scholar
• Fokom Defo V, Fokom Domgue J. Why consider self-sampling for cervical cancer screening in low- and middle-income countries? JAMA Ethics. 2020;22(2):116–125. doi:10.1001/amajethics.2020.116
   Google Scholar
• Campos NG, Alfaro K, Maza M, et al. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Prev Med (Baltim). 2020;131:105931. doi:10.1016/j.ypmed.2019.105931
   Web of Science ®Google Scholar
• Ho IK, Dinh KT. Cervical cancer screening among Southeast Asian American Women. J Immigr Minor Health. 2011;13(1):49–60. doi:10.1007/s10903-010-9358-0
   Web of Science ®Google Scholar
• Mangold BR. Self-collected samples in cervical cancer screening: results of HPV and pap self-collected samples compared to physician-obtained specimens. Acta Cytol. 2019;63:379–384. doi:10.1159/000499373
   Web of Science ®Google Scholar
• Garcia F, Barker B, Santos C, et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol. 2003;102(2):266–272. doi:10.1016/S0029-7844(03)00517-9
   PubMed Web of Science ®Google Scholar
• Brink AATP, Meijer CJLM, Wiegerinck MAHM, et al. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol. 2006;44:2518–2523. doi:10.1128/JCM.02440-05
   PubMed Web of Science ®Google Scholar
• Othman NH, Mohamad Zaki FH, Nik Hussain NH, Wan Yusoff WZ, Ismail P. Self-sampling versus physicians’ sampling for cervical cancer screening - agreement of cytological diagnoses. Asian Pacific J Cancer Prev. 2016;17(7):3489–3494. doi:10.1016/j.pathol.2015.12.402
   Google Scholar
• Singla AA, Komesaroff P. Self-collected Pap smears may provide an acceptable and effective method of cervical cancer screening. Health Sci Rep. 2018;1:e33. doi:10.1002/hsr2.33
   Google Scholar
• Da Silva Rocha A, Schaeffer PG, Meurer L, Hartmann CR, Edelweiss MIA. Assessment of the fournier® cervical specimen self-sampling device using the papanicolaou method. Acta Cytol. 2012;56:520–526. doi:10.1159/000341239
   Web of Science ®Google Scholar
• Budge M, Halford J, Haran M, Mein J, Wright G. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology. Aust New Zeal J Obstet Gynaecol. 2005;45:215–219. doi:10.1111/j.1479-828X.2005.00392.x
   PubMed Web of Science ®Google Scholar
• Jones HE, Mansukhani MM, Tong GX, Westhoff CL, Baradaran HR. Validity and reliability of using a self-lavaging device for cytology and hpv testing for cervical cancer screening: findings from a pilot study. PLoS One. 2013;8:e82115. doi:10.1371/journal.pone.0082115
   Web of Science ®Google Scholar
• Loopik DL, Melchers WJG, Vedder JEM, et al. Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study. BJOG Int J Obstet Gynaecol. 2020;127(13):1656–1663. doi:10.1111/1471-0528.16352
   Web of Science ®Google Scholar
• Wentzensen N, von Knebel Doeberitz M. Biomarkers in cervical cancer screening. Dis Markers. 2007;23:315–330. doi:10.1155/2007/678793
   PubMed Web of Science ®Google Scholar
• Gradíssimo A, Burk RD. Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention. Expert Rev Mol Diagn. 2017;17:379–391. doi:10.1080/14737159.2017.1293525
   PubMed Web of Science ®Google Scholar
• Fan Y, Meng Y, Yang S, et al. Screening of cervical cancer with self-collected cervical samples and next-generation sequencing. Dis Markers. 2018;2018:1–4. doi:10.1155/2018/4826547
   Web of Science ®Google Scholar
• Xu B, Chotewutmontri S, Wolf S, et al. Multiplex identification of human papillomavirus 16 DNA integration sites in cervical carcinomas. PLoS One. 2013;8:e66693. doi:10.1371/journal.pone.0066693
   Web of Science ®Google Scholar
• Bowden SJ, Kalliala I, Veroniki AA, et al. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: a systematic review and meta-analysis. EBioMedicine. 2019;50:246–259. doi:10.1016/j.ebiom.2019.10.053
   PubMed Web of Science ®Google Scholar
• Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer. 2019;121:954–965. doi:10.1038/s41416-019-0593-4
   PubMed Web of Science ®Google Scholar
• El Aliani A, El-Abid H, El Mallali Y, Attaleb M, Ennaji MM, El Mzibri M. Association between gene promoter methylation and cervical cancer development: global distribution and a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2021;30:450–459. doi:10.1158/1055-9965.EPI-20-0833
   Web of Science ®Google Scholar
• Chang CC, Huang RL, Liao YP, et al. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm. BMC Cancer. 2015;15:1–9. doi:10.1186/s12885-015-1411-x
   Web of Science ®Google Scholar
• Gillio-Tos A, Fiano V, Grasso C, et al. Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing. PLoS One. 2018;13:e0194619. doi:10.1371/journal.pone.0194619
   Web of Science ®Google Scholar
• De Vuyst H, Alemany L, Lacey C, et al. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31:F32–F46. doi:10.1016/j.vaccine.2012.07.092
   PubMed Web of Science ®Google Scholar
• Onyango CG, Ogonda L, Guyah B, et al. Novel biomarkers with promising benefits for diagnosis of cervical neoplasia: a systematic review. Infect Agent Cancer. 2020;15:1–2. doi:10.1186/s13027-020-00335-2
   Web of Science ®Google Scholar
• Yu L, Fei L, Liu X, Pi X, Wang L, Chen S. Application of p16/Ki-67 dual-staining cytology in cervical cancers. J Cancer. 2019;10:2654–2660. doi:10.7150/jca.32743
   Web of Science ®Google Scholar
• Wentzensen N, Schwartz L, Zuna RE, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18:4154–4162. doi:10.1158/1078-0432.CCR-12-0270
   PubMed Web of Science ®Google Scholar
• Luttmer R, Dijkstra MG, Snijders PJF, et al. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population. Mod Pathol. 2016;29:870–878. doi:10.1038/modpathol.2016.80
   PubMed Web of Science ®Google Scholar
• Ebisch RMF, Van Der Horst J, Hermsen M, et al. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. Mod Pathol. 2017;30:1021–1031. doi:10.1038/modpathol.2017.16
   PubMed Web of Science ®Google Scholar
• Mandal R, Ghosh I, Banerjee D, et al. Correlation between p16/Ki-67 expression and the grade of cervical intraepithelial neoplasias. Int J Gynecol Pathol. 2020;39:384–390. doi:10.1097/PGP.0000000000000617
   Web of Science ®Google Scholar
• Prevodnik VK, Marinsek ZP, Zalar J, et al. Evaluation of the training program for p16/Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry. Radiol Oncol. 2020;54:201–208. doi:10.2478/raon-2020-0018
   Web of Science ®Google Scholar
• Ziemke P. P16/Ki-67 immunocytochemistry in gynecological cytology: limitations in practice. Acta Cytol. 2017;61:230–236. doi:10.1159/000475979
   Web of Science ®Google Scholar
• Toliman PJ, Phillips S, de Jong S, et al. Evaluation of p16/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer. Clin Microbiol Infect. 2020;26:748–752. doi:10.1016/j.cmi.2019.10.020
   Web of Science ®Google Scholar
• Orang’O EO, Were E, Rode O, et al. Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya. Infect Agent Cancer. 2020;15:1. doi:10.1186/s13027-020-00323-6
   Web of Science ®Google Scholar
• Derbie A, Mekonnen D, Woldeamanuel Y, Van Ostade X, Abebe T. HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review. Infect Agent Cancer. 2020;15:1. doi:10.1186/s13027-020-0278-x.
   Web of Science ®Google Scholar
• Macedo ACL, Gonçalves JCN, Bavaresco DV, Grande AJ, Chiaramonte Silva N, Rosa MI. Accuracy of mRNA HPV tests for triage of precursor lesions and cervical cancer: a systematic review and meta-analysis. J Oncol. 2019;2019:1–14. doi:10.1155/2019/6935030
   Web of Science ®Google Scholar
• Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer. 2018;18:1–7. doi:10.1186/s12885-018-4590-4.
   Web of Science ®Google Scholar
• Burger EA, Sy S, Nygard M, Kristiansen IS, Kim JJ. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One. 2014;9:e89974. doi:10.1371/journal.pone.0089974
   PubMed Web of Science ®Google Scholar
• Burger EA, Sy S, Nygard M, Kim JJ. The cost-effectiveness of cervical self-sampling to improve routine cervical cancer screening: the importance of respondent screening history and compliance. Cancer Epidemiol Biomarkers Prev. 2017;26:95–103. doi:10.1158/1055-9965.EPI-16-0350
   Web of Science ®Google Scholar
• Aarnio R, Östensson E, Olovsson M, Gustavsson I, Gyllensten U. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study. BMC Cancer. 2020;20:1–9. doi:10.1186/s12885-020-07085-9.
   Web of Science ®Google Scholar
• Medical Services Advisory Committee. MSAC outcomes public summary document: application no. 1276 – renewal of the National Cervical Screening Program. 2014.
   Google Scholar
• Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JSA, Parham GP. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ. 2008;86:D–E. doi:10.2471/blt.08.056275
   Google Scholar
• Odafe S, Torpey K, Khamofu H, et al. Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J. 2013;54:176. doi:10.4103/0300-1652.114590
   Google Scholar
• Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018;190:E422–E429. doi:10.1503/cmaj.171154
   PubMed Web of Science ®Google Scholar
• Wilson JMG, Jungner G, WHO WHO. Principles and practice of screening for disease / J. M. G. Wilson, G. Jungner. Public Health Pap. Published online 1968;123(3):349. doi:10.1001/archinte.1969.00300130131020
   Google Scholar
• Poljak M, Oštrbenk Valenčak A, Gimpelj Domjanič G, Xu L, Arbyn M. Commercially available molecular tests for human papillomaviruses: a global overview. Clin Microbiol Infect. 2020;26:1144–1150. doi:10.1016/j.cmi.2020.03.033
   PubMed Web of Science ®Google Scholar
• Hoste G, Vossaert K, Poppe WAJ. The clinical role of HPV testing in primary and secondary cervical cancer screening. Obstet Gynecol Int. 2013;2013:1–7. doi:10.1155/2013/610373
   Google Scholar
• Denny L, de Sanjose S, Mutebi M, et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet. 2017;389:861–870. doi:10.1016/S0140-6736(16)31795-0
   PubMed Web of Science ®Google Scholar
• Nath J, Bhattacharyya A, Deka H. Comparative study between pap smear and visual inspection with acetic acid (via) in screening of CIN and early cervical cancer. J Midlife Health. 2015;6:53. doi:10.4103/0976-7800.158942
   Google Scholar
• Gravitt PE, Paul P, Katki HA, et al. Effectiveness of VIA, pap, and HPV DNA testing in a cervical cancer screening program in a Peri-Urban community in Andhra Pradesh, India. PLoS One. 2010;5:e13711. doi:10.1371/journal.pone.0013711
   Web of Science ®Google Scholar
• de Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–459. doi:10.1016/S1473-3099(07)70158-5
   PubMed Web of Science ®Google Scholar